The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.
2214 GMT – Citi analyst Laura Sutcliffe remains cautious on Ramsay Health Care despite the private-hospital operator’s stronger-than-expected 1Q revenue and earnings. She points out in a note to clients that the Australian company’s September-quarter performance is influenced by hospitalizations from the country’s flu season. Sutcliffe raises her full-year Australia Ebit margin to 9.3% to 8.8%, but declines to fully translate the 1Q beat across the whole of fiscal 2026. Investors would like to see Ramsay give explicit margin targets, she adds. Citi lifts its target price 9.1% to A$36.00 and keeps a neutral rating on the stock. Shares are at A$35.95 ahead of the open. (stuart.condie@wsj.com)
Copyright ©2025 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8